Skip to main content
. 2015 Feb 1;9(2):DC13–DC15. doi: 10.7860/JCDR/2015/12092.5560

[Table/Fig-1]:

Individual antibiotic class limitation in RTI management

Class Limitation
β-lactam No activity against atypical pathogen and development of S. pneumoniae resistant isolates > 50 %
Macrolides 30.9 % resistant S. pneumoniae isolates reported
Fluroquinolones Increase potential for emergence of resistant strain of gram negative microorganism